Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer

Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer

Abstract Ubiquitin-Specific Protease 39 (USP39) has been implicated in numerous malignancies, however, its pathogenic mechanisms and impact on the tumor immune microenvironment (TIME) remain incompletely characterized. Based on The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx)...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiahui Yuan, Beibei Xu, Yongcheng Su, Pingping Zhang, Xianbin Zhang, Peng Gong
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Cancer
Subjects:
USP39
Pancreatic cancer
Prognosis
Tumor microenvironment
Immunotherapy
Online Access:https://doi.org/10.1186/s12885-025-14096-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items